If you are eligible for the Arikayce patient assistance program, the cost of your medication will be free. We only charge $49 per month for each medication, to cover our service fees. You could receive your Arikayce prescription for just $49 a month, regardless of the retail price of your medication.
Full Answer
How do I enroll in the arikayce prescription and arikares support program?
ARIKAYCE Prescription and Arikares Support Program Enrollment Form Fax: 1-800-604-6027or E-mail:[email protected] Please complete all fields on page 1 and 3 to prevent any delays and include scanned copies of both sides of the patient’s insurance card (fields marked with an asterisk [*] are mandatory/required). INDICATION
What is the arikares support program?
The Arikares Support Program may also provide information about insurance coverage and financial support options for eligible patients. Have questions? Have questions? Scroll down to discover more about the Arikares Support Program . What is ARIKAYCE?
Who is eligible for arikayce co-pay?
Patients who have been prescribed ARIKAYCE, are at least 18 years of age, a resident of the 50 United States, the District of Columbia, or Puerto Rico, and have commercial or private health insurance may be eligible for the ARIKAYCE Co-pay Savings Program. ARIKAYCE must be covered by your commercial or private insurance.
What is arikayce?
What is ARIKAYCE? ARIKAYCE is a prescription medicine used to treat adults with refractory (difficult to treat) Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug treatment plan (regimen). It is not known if ARIKAYCE is safe and effective in children younger than 18 years of age.
What is Arikayce used for?
How to report side effects of Arikayce?
How old is too old to take Arikayce?
Can you die from taking Arikayce?
Does Arikayce cause kidney problems?
Does Arikayce cause muscle weakness?
Can you take Arikayce if you are allergic to it?
See 2 more
How much does Arikayce cost?
Arikayce cost without insurance will vary depending on where you buy it. As a guide, Arikayce suspension for nebulization 590 mg/8.4 ml, usually costs $1,800 for 30 milliliters. With NiceRx you will pay a flat monthly fee of $49, regardless of the retail price of your medication.
What does Arikayce treat?
The U.S. Food and Drug Administration today approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment ( ...
Is Arikayce covered by Medicare?
Arikayce is a prescription antibiotic medication used to treat Mycobacterium avium complex (MAC) lung disease in adults who have few or no other treatment options. This medication comes in the form of an inhalation suspension and is not covered by Medicare.
Is Arikayce limited distribution?
LIMITED POPULATION: ARIKAYCE® is indicated in adults, who have limited or no alternative treatment options, for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen in patients who do not achieve negative sputum cultures after a minimum of 6 consecutive ...
How long can you take Arikayce?
The inhaled liposomal formulation of ARIKAYCE delivers the medication directly to the lungs at the site where the MAC bacteria infection is. Adding ARIKAYCE is proven to help patients test MAC negative for 12 months and beyond.
How long is Arikayce treatment?
The recommended dose of ARIKAYCE in adults is the once-daily inhalation of the contents of one 590 mg/8.4 mL ARIKAYCE vial using the Lamira Nebulizer System. Administer for approximately 14 minutes with the Lamira Nebulizer System. Treatment time may vary and could take up to 20 minutes.
Who makes Arikayce?
1. ARIKAYCE {package insert]. Bridgewater, NJ: Insmed Incorporated; 2020.
What is MAC lung condition?
MAC lung disease is an infection caused a group of bacteria called Mycobacterium avium complex (MAC). MAC includes two closely related species, Mycobacterium avium and Mycobacterium intracellulare, and may also be referred to as MAI.
What is ethambutol used to treat?
Ethambutol is used to treat tuberculosis (TB). It is used with other medicines for TB. This medicine may also be used for other problems as determined by your doctor.
What type of drug is Arikayce?
Arikayce is an antibiotic that is used to treat Mycobacterium avium complex (MAC) lung disease in adults who have few or no other treatment options. This medicine is given in combination with other antibiotics.
What is the major side effect of amikacin?
Amikacin injection is usually used for serious bacterial infections for which other medicines may not work. However, it may also cause some serious side effects, including damage to your hearing, sense of balance, and kidneys. These side effects may be more likely to occur in elderly patients and newborn infants.
Is amikacin an antibiotic?
Amikacin belongs to a class of drugs known as aminoglycoside antibiotics. It works by stopping the growth of bacteria.
When was Arikayce approved?
Development timeline for ArikayceDateArticleSep 28, 2018Approval FDA Approves Arikayce (amikacin liposome inhalation suspension) to treat Mycobacterium Avium Complex (MAC) Lung DiseaseOct 3, 2018
What is the lung condition called MAC?
Pulmonary Mycobacterium avium complex (MAC) infection causes chronic pulmonary diseases. MAC occurs in the natural environment and the common source of infection appears to be water, soil or dust, with human-to-human transmission considered uncommon 1–3.
Arikayce Uses, Side Effects & Warnings - Drugs.com
Warnings. Arikayce can cause a life-threatening allergic reaction. Stop using this medicine and get emergency medical help if you have symptoms such as: cough, trouble breathing, itching or hives, vomiting, diarrhea, fast heartbeats, feeling light-headed, or swelling in your face or throat. Arikayce can cause breathing problems.
Arikayce Prices, Coupons & Savings Tips - GoodRx
Compare prices, print coupons and get savings tips for Arikayce and other Bacterial Infection drugs at CVS, Walgreens, and other pharmacies.
ARIKAYCE Prescription and Arikares Support Program Enrollment Form
PATIENT AUTHORIZATION By signing the Patient Authorization block on page 1, I authorize my healthcare providers, including the pharmacies I use, and my health insurance plan(s) to disclose my personal information, including
Arikayce (liposomal amikacin for inhalation) for COPD
Arikayce (liposomal amikacin for inhalation, also known as LAI) is an approved therapy developed by the pharmaceutical company Insmed for the treatment of serious chronic lung infections, such as non-tuberculosis mycobacterium (NTM).. NTM is caused by bacteria found in the soil and water, and its prevalence is increasing worldwide. Common symptoms include fever, weight loss, blood in the ...
Arikayce (Liposomal Amikacin for Inhalation) - Bronchiectasis News Today
Arikayce (liposomal amikacin for inhalation, or LAI), by Insmed, is approved to treat adults with few or no treatment options for lung infections caused by Mycobacterium avium complex (MAC), a type of non-tuberculous mycobacteria (NTM).. Arikayce consists of liposomes that contain amikacin, an antibiotic used to treat severe or serious bacterial infections.
What is Arikayce used for?
LIMITED POPULATION: ARIKAYCE®is indicated in adults, who have limited or no alternative treatment options, for the treatment of Mycobacterium aviumcomplex (MAC) lung disease as part of a combination antibacterial drug regimen in patients who do not achieve negative sputum cultures after a minimum of 6 consecutive months of a multidrug background regimen therapy. As only limited clinical safety and effectiveness data for ARIKAYCE are currently available, reserve ARIKAYCE for use in adults who have limited or no alternative treatment options. This drug is indicated for use in a limited and specific population of patients. This indication is approved under accelerated approval based on achieving sputum culture conversion (defined as 3 consecutive negative monthly sputum cultures) by Month 6. Clinical benefit has not yet been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
What are the side effects of Arikayce?
The most common side effects of ARIKAYCE include: changes in voice and hoarseness (dysphonia), cough during or after a dose of ARIKAYCE, especially in the first month after starting treatment, muscle pain, sore throat, tiredness (fatigue), diarrhea, nausea, headache, fever, decreased weight, vomiting, rash, increased sputum, or chest discomfort. These are not all of the possible side effects of ARIKAYCE. Call your doctor or pharmacist for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Please see additional Important Safety Information and full Prescribing Information, including Boxed Warning.
How to contact Arikares?
Fax: 1-800-604-6027or E-mail:[email protected] Please complete all fields on page 1 and 3 to prevent any delays and include scanned copies of both sides of the patient’s insurance card (fields marked with an asterisk
- ] are mandatory/required).
What page is the warning for Arikayce?
Please see Indication and Important Safety Information for ARIKAYCE, including Boxed Warning, on page 4. Please see accompanying full Prescribing Information. Pg 3 of 4
Does Arikayce cause hemoptysis?
Hemoptysishas been reported with the use of ARIKAYCE in the clinical trials. Hemoptysis was reported at a higher frequency in patients treated with ARIKAYCE plus background regimen (17.9%) compared to patients treated with a background regimen alone (12.5%). If hemoptysis occurs, manage patients as medically appropriate.
Is Arikayce safe for MAC lung disease?
Limitation of Use: ARIKAYCE has only been studied in patients with refractory MAC lung disease defined as patients who did not achieve negative sputum cultures after a minimum of 6 consecutive months of a multidrug background regimen therapy. The use of ARIKAYCE is not recommended for patients with non-refractory MAC lung disease.
Is Arikayce contraindicated?
Contraindications: ARIKAYCE is contraindicated in patients with known hypersensitivity to any aminoglycoside.
How to enroll in Arikares?
Complete the Arikares Enrollment Form with your patients to help them get started with ARIKAYCE. Submit via fax (1-800-604-6027) or email ([email protected]).
Is Arikayce a congenital deaf drug?
Aminoglycosides, including ARIKAYCE, may be associated with total, irreversible, bilateral congenital deafness in pediatric patients exposed in utero. Patients who use ARIKAYCE during pregnancy, or become pregnant while taking ARIKAYCE should be apprised of the potential hazard to the fetus.
Does Arikayce cause ototoxicity?
Ototoxicity has been reported with the use of ARIKAYCE in the clinical trials. Ototoxicity (including deafness, dizziness, presyncope, tinnitus, and vertigo) were reported with a higher frequency in patients treated with ARIKAYCE plus background regimen (17%) compared to patients treated with background regimen alone (9.8%). This was primarily driven by tinnitus (8.1% in ARIKAYCE plus background regimen vs 0.9% in the background regimen alone arm) and dizziness (6.3% in ARIKAYCE plus background regimen vs 2.7% in the background regimen alone arm). Closely monitor patients with known or suspected auditory or vestibular dysfunction during treatment with ARIKAYCE. If ototoxicity occurs, manage patients as medically appropriate, including potentially discontinuing ARIKAYCE.
Does Arikayce cause hemoptysis?
Hemoptysis has been reported with the use of ARIKAYCE in the clinical trials. Hemoptysis was reported at a higher frequency in patients treated with ARIKAYCE plus background regimen (18.4%) compared to patients treated with background regimen alone (13.4%). If hemoptysis occurs, manage patients as medically appropriate.
Is Arikayce contraindicated?
Contraindications: ARIKAYCE is contraindicated in patients with known hypersensitivity to any aminoglycoside.
Is Arikayce a respiratory drug?
WARNING: RISK OF INCREASED RESPIRATORY ADVERSE REACTIONS. ARIKAYCE has been associated with an increased risk of respiratory adverse reactions, including hypersensitivity pneumonitis, hemoptysis, bronchospasm, and exacerbation of underlying pulmonary disease that have led to hospitalizations in some cases.
Does Arikayce cause bronchospasm?
ARIKAYCE has been associated with an increased risk of respiratory adverse reactions, including hypersensitivity pneumonitis, hemoptysis, bronchospasm, and exacerbation of underlying pulmonary disease that have led to hospitalizations in some cases.
What is Arikayce used for?
What is ARIKAYCE? ARIKAYCE is the first and only FDA-approved treatment option designed specifically to treat MAC lung disease as part of a combination antibacterial drug treatment plan in patients who did not respond to a combination antibacterial drug treatment alone.
What is Arikares support?
The Arikares Support Program provides ongoing support and resources along your treatment journey. As you take ARIKAYCE ® (amikacin liposome inhalation suspension), you'll receive tools to help you become familiar with how to use your device, find information that may help you establish a treatment routine, and find other information or resources. The Arikares Support Program may also provide information about insurance coverage and financial support options for eligible patients.
What pathway was a syringe approved by?
This product was approved by the FDA using the Limited Population pathway . This means the FDA has approved this drug for a limited and specific patient population, and studies of the drug may have only answered focused questions about its safety and effectiveness.
What is the primary point of contact for a patient?
He or she will be your primary point of contact throughout your treatment journey to provide important information and support along the way.
Can Arikares trainer replace doctor?
Your Arikares Trainer is not intended to replace the direction provided by your doctor.
What is a PAP?from boehringer-ingelheim.us
The PAP is one of the four core programs of Boehringer Ingelheim Cares Foundation. The other programs include the Product Donation Program, Financial Contributions Program, and Employee Volunteer Program. Through these programs, Boehringer Ingelheim provides more health in local U.S. communities and around the world. About Boehringer Ingelheim.
What is BI Cares?from boehringer-ingelheim.com
The US-based Boehringer Ingelheim Cares Foundation (BI Cares), an independent nonprofit organization, is making monetary donations and donating urgently needed medicines for patients through our non-governmental organization (NGO) partners. BI Cares added a new cause to its Matching Gifts Program to provide Boehringer Ingelheim US employees the opportunity to double the impact of their charitable giving to a fund being used to prevent the spread of and help those affected by COVID-19. The Foundation is also temporarily increasing the quantity or frequency of prescription medicine refills for all covered medicines to eligible US patients enrolled in its charitable Patient Assistance Program to assure patients they can remain adherent to the treatment they need for their medical conditions.
What is PAP in Boehringer Ingelheim?from boehringer-ingelheim.us
The PAP is one of the four core programs of Boehringer Ingelheim Cares Foundation.
What is Arikayce used for?
ARIKAYCE is a prescription medicine used to treat adults with refractory (difficult to treat) Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug treatment plan (regimen).
How to report side effects of Arikayce?
Call your doctor or pharmacist for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda. gov/medwatch.
How old is too old to take Arikayce?
It is not known if ARIKAYCE is safe and effective in children younger than 18 years of age.
Can you die from taking Arikayce?
serious allergic reactions. Serious allergic reactions that may lead to death have happened to people who take ARIKAYCE. Stop taking ARIKA YCE right away and get emergency medical help if you have any of the following symptoms of a serious allergic reaction: hives, itching, redness or blushing of the skin (flushing), swollen lips, tongue or throat, trouble breathing or wheezing, shortness of breath, noisy high-pitched breathing (stridor), cough, nausea, vomiting, diarrhea, feel cramps in your stomach area, fast heart rate, feeling light headed, feeling faint, loss of control of the bowels or bladder (incontinence), and dizziness
Does Arikayce cause kidney problems?
ARIKAYCE is in a class of medicines which may cause worsening kidney problems. Your healthcare provider may do a blood test to check how well your kidneys are working during your treatment with ARIKAYCE. worsening muscle weakness (neuromuscular blockade).
Does Arikayce cause muscle weakness?
worsening muscle weakness (neuromuscular blockade). ARIKAYCE is in a class of medicines which can cause muscle weakness to get worse in people who already have problems with muscle weakness (myasthenia gravis)
Can you take Arikayce if you are allergic to it?
Do not use ARIKAYCE if you are allergic to any aminoglycoside, or any of the ingredients in ARIKAYCE.
